Roche Holding AG (RHHBY)
32.81
+0.16
(+0.49%)
USD |
OTCM |
May 17, 16:00
Roche Price to Book Value: 5.996 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 17, 2024 | 5.996 |
May 16, 2024 | 5.967 |
May 15, 2024 | 5.738 |
May 14, 2024 | 5.656 |
May 13, 2024 | 5.546 |
May 10, 2024 | 5.656 |
May 09, 2024 | 5.647 |
May 08, 2024 | 5.559 |
May 07, 2024 | 5.57 |
May 06, 2024 | 5.499 |
May 03, 2024 | 5.451 |
May 02, 2024 | 5.347 |
May 01, 2024 | 5.437 |
April 30, 2024 | 5.449 |
April 29, 2024 | 5.543 |
April 26, 2024 | 5.528 |
April 25, 2024 | 5.486 |
April 24, 2024 | 5.581 |
April 23, 2024 | 5.709 |
April 22, 2024 | 5.649 |
April 19, 2024 | 5.557 |
April 18, 2024 | 5.491 |
April 17, 2024 | 5.497 |
April 16, 2024 | 5.524 |
April 15, 2024 | 5.588 |
Date | Value |
---|---|
April 12, 2024 | 5.590 |
April 11, 2024 | 5.658 |
April 10, 2024 | 5.590 |
April 09, 2024 | 5.603 |
April 08, 2024 | 5.517 |
April 05, 2024 | 5.526 |
April 04, 2024 | 5.619 |
April 03, 2024 | 5.720 |
April 02, 2024 | 5.734 |
April 01, 2024 | 5.839 |
March 28, 2024 | 5.833 |
March 27, 2024 | 5.722 |
March 26, 2024 | 5.722 |
March 25, 2024 | 5.718 |
March 22, 2024 | 5.724 |
March 21, 2024 | 5.724 |
March 20, 2024 | 5.961 |
March 19, 2024 | 5.870 |
March 18, 2024 | 5.881 |
March 15, 2024 | 5.965 |
March 14, 2024 | 6.010 |
March 13, 2024 | 6.254 |
March 12, 2024 | 6.423 |
March 11, 2024 | 6.325 |
March 08, 2024 | 6.195 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.347
Minimum
May 02 2024
12.77
Maximum
Apr 08 2022
8.476
Average
8.356
Median
Nov 05 2021
Price to Book Value Benchmarks
Novartis AG | 5.275 |
Pfizer Inc | 1.759 |
ADC Therapeutics SA | -- |
Lonza Group Ltd | 3.723 |
Sarepta Therapeutics Inc | 12.92 |
Price to Book Value Related Metrics
PE Ratio | 16.40 |
PS Ratio | 3.116 |
Price to Free Cash Flow | 16.46 |
Price | 32.81 |
Earnings Yield | 6.10% |
Market Cap | 209.26B |
Operating PE Ratio | 12.26 |
Normalized PE Ratio | 16.21 |